These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1026295)

  • 1. [Accelerin (factor V), the catobolic product of fibrinogen ].
    Chulkova T; Victoreo L
    Biull Eksp Biol Med; 1976 Aug; 82(8):950-2. PubMed ID: 1026295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic properties and molecular size of thrombin-activated favtor V.
    Colman RW; Moran J; Philip G
    J Biol Chem; 1970 Nov; 245(22):5941-6. PubMed ID: 5530157
    [No Abstract]   [Full Text] [Related]  

  • 3. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of the effect of thrombin on macromolecular substrates].
    Sereiskaia AA; Strukova SM
    Dokl Akad Nauk SSSR; 1985; 282(2):481-4. PubMed ID: 4017865
    [No Abstract]   [Full Text] [Related]  

  • 5. Ac-globulin (Factor V): preparation of a practical product.
    Dombrose FA; Yasui T; Roubal Z; Roubal A; Seegers WH
    Prep Biochem; 1972; 2(4):381-96. PubMed ID: 4673387
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiological effects of the plasminolytic derivatives of fibrinogen.
    Triantaphyllopoulos DC
    Prog Clin Biol Res; 1976; 5():121-45. PubMed ID: 9646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
    Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
    Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat coagulation factor V purification and production of the monospecific antiserum.
    Cornillon B; Paul J; Mazzorana M; Belleville J
    Comp Biochem Physiol B; 1986; 83(2):397-401. PubMed ID: 3956160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin.
    Chahal G; Thorpe M; Hellman L
    PLoS One; 2015; 10(6):e0129511. PubMed ID: 26110612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin and haemostasis: regulation of the biological functions of thrombin. (Facts and perspectives).
    Machovich R; Horváth I
    Haematologia (Budap); 1981 Dec; 14(4):339-59. PubMed ID: 6178655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation tests from capillary blood. Determination of thromboplastin time, thrombin time, fibrinogen, factor II (prothrombin), factor V (accelerin) and factor X (Stuart-Prower factor) from capillary blood].
    Muntean W
    Z Kinderheilkd; 1975; 118(4):337-46. PubMed ID: 1130122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of rabbit anti-bovine prothrombin/thrombin IgGs with bovine factor V/Va-related antigens.
    He Zhu ; Hoppensteadt D; Morris M; Fareed J
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):522-8. PubMed ID: 20699260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standards and stability study of the fibrinogen preparation put out by blood transfusion centers].
    Laricheva NI; Karlova NG; Nazarchuk LV; Zubova NV; Voloshina MS
    Probl Gematol Pereliv Krovi; 1979 Apr; 24(4):47-50. PubMed ID: 432236
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemorrhagic syndrome in dogs induced by intravenous thrombin.
    Girolami A; Cliffton EE; Agostino D
    Thromb Diath Haemorrh; 1966 Jul; 16(1):243-56. PubMed ID: 5989044
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of the formation and activity of factor V-phospholipid complexes. I. Influence of phospholipid structure.
    Kandall CL; Shohet SB; Akinbami TK; Colman RW
    Thromb Diath Haemorrh; 1975 Sep; 34(1):256-70. PubMed ID: 1237944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preparation and properties of a stable factor V from bovine plasma.
    Barton PG; Hanahan DJ
    Biochim Biophys Acta; 1967 Apr; 133(3):506-18. PubMed ID: 6068006
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of Vipera berus venom on the activity of some coagulation factors].
    Bruno C; Cuppini R; Valora N
    Boll Soc Ital Biol Sper; 1981 Sep; 57(18):1859-61. PubMed ID: 7317178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.